Title : Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC.

Pub. Date : 2014

PMID : 25222296






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC. Platinum caveolin 1 Homo sapiens
2 CONCLUSIONS: CAV1 methylation is a predictor of disease stabilization and improved overall survival following chemotherapy with a taxane-platinum combination regimen in advanced NSCLC. Platinum caveolin 1 Homo sapiens